Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Sponsor: Zenas BioPharma (USA), LLC
Summary
This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis
Official title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With Relapsing Multiple Sclerosis
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
93
Start Date
2024-08-26
Completion Date
2026-02
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
Obexelimab
Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcyRIIb, resulting in down regulation of B cell activity
Placebo
Placebo
Locations (47)
North Central Neurology
Cullman, Alabama, United States
Center for Neurology and Spine
Phoenix, Arizona, United States
Perseverance Research Center
Scottsdale, Arizona, United States
Regina Berkovich MD PhD, Inc
West Hollywood, California, United States
Aqualine Clinical Research
Naples, Florida, United States
University of South Florida
Tampa, Florida, United States
University of Massachusetts Medical School
Worcester, Massachusetts, United States
Infusion Associates Plymouth
Plymouth, Minnesota, United States
MS Center for Innovations in Care
St Louis, Missouri, United States
Holy Name Medical Center
Teaneck, New Jersey, United States
Boster Center for MS
Columbus, Ohio, United States
North Texas Institute of Neurology and Headache
Plano, Texas, United States
Center for Neurological Disorders
Greenfield, Wisconsin, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Neuro-logisch Wien
Vienna, Austria
Rehabilitation & MS Center, Noorderhart Hospital
Overpelt, Belgium
AZ Delta-Deltalaan 1
Roeselare, Belgium
Tiantan Hospital, Capital Medical University
Beijing, China
The First Affiliation Hospital of Soochow University
Suzhou, China
Tianjin Medical University General Hospital
Tianjin, China
People's Hospital of Xinjiang Uyaur Autonomous Region
Ürümqi, China
Tongji Hospital, Tongji Medical Center of HUST
Wuhan, China
Klinicki bolnicki centar Zagreb
Zagreb, Croatia
Fakultni nemocnice u sv. Anny v Brne
Brno, Czechia
Nemocnice Jihlava
Jihlava, Czechia
General University Hospital Praha
Prague, Czechia
Aalborg Universitetshospital
Aalborg, Denmark
Attikon University General Hospital
Chaïdári, Greece
University General Hospital of Larissa
Larissa, Greece
Fondazione Isituto G. Giglio di Cefalu
Cefalù, Italy
University of Florence
Florence, Italy
Istituto Neurologico Mediterraneo Neuromed
Pozzilli, Italy
Fondazione PTV Policlinico Tor Vergata
Roma, Italy
Neurocentrum Bydgoszcz sp.z o.o.
Bydgoszcz, Poland
M.A. LEK A.M. Maciejowsy Spolka Cywilna
Katowice, Poland
Zanamed Medical Clinic Sp z o.o.
Lublin, Poland
Wielospecjalistyczne Centrum Medyczne Ibismed
Zabrze, Poland
Hospital Clinico San Carlos
Madrid, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Hospital Regional Universitario de Malaga - Hospital General
Málaga, Spain
Hospital Regional Universitario de Malaga
Málaga, Spain
Hospital Universitario Virgen de La Arrixaca
Murcia, Spain
Hospital Virgen Macarena
Seville, Spain
Hospipal La Fe Valencia
Valencia, Spain
Leicester General Hospital
Leicester, United Kingdom
Barts Health NHS Trust
London, United Kingdom
Morriston Hospital
Swansea, United Kingdom